Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
259
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
+854K
-
Total reported value, excl. options
-
$1.06B
-
Value change
-
+$87M
-
Put/Call ratio
-
1.75
-
Number of buys
-
143
-
Number of sells
-
-122
-
Price
-
$103.67
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q1 2023
323 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q1 2023.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 10.9M outstanding shares and own 93.74% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.79M shares), VANGUARD GROUP INC (1.72M shares), RENAISSANCE TECHNOLOGIES LLC (651K shares), MILLENNIUM MANAGEMENT LLC (399K shares), STATE STREET CORP (380K shares), MORGAN STANLEY (362K shares), DIMENSIONAL FUND ADVISORS LP (333K shares), PRINCIPAL FINANCIAL GROUP INC (223K shares), GEODE CAPITAL MANAGEMENT, LLC (221K shares), and Bank of New York Mellon Corp (186K shares).
This table shows the top 259 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.